Today: 7 February 2026
Subscribe
Browse Category

NYSE:GPN News 14 December 2025 - 14 January 2026

Fiserv stock edges up as Clover lands CareCredit expansion — here’s what traders watch next

Fiserv stock edges up as Clover lands CareCredit expansion — here’s what traders watch next

Fiserv shares rose 0.1% to $66.81 Wednesday afternoon, bucking a broader market slide as the S&P 500 ETF fell 0.8%. Synchrony expanded CareCredit integration with Fiserv’s Clover platform, now reaching over 40,000 providers. Investors await Fiserv’s next earnings date, still unconfirmed. The stock remains volatile after October’s outlook cut and leadership changes.
14 January 2026
······
Payments & Fintech US Stocks Week Ahead: Visa’s Stablecoin Re-Rating, PayPal’s Checkout Crunch, and the Post-Fed Data Wave (Dec 15–19, 2025)

Payments & Fintech US Stocks Week Ahead: Visa’s Stablecoin Re-Rating, PayPal’s Checkout Crunch, and the Post-Fed Data Wave (Dec 15–19, 2025)

Updated: December 14, 2025 US-listed payments and fintech stocks head into the next trading week with two forces pulling in opposite directions: a Federal Reserve that just delivered another rate cut — but is signaling patience from here — and a market bracing for a backlog of delayed economic reports that could quickly rewrite the “soft landing vs. slowdown” narrative. Reuters+1 That setup matters more than usual for this corner of the market. Payments names (Visa, Mastercard, Global Payments, Fiserv, FIS, Shift4, Toast) and consumer-fintech platforms (PayPal, Block, SoFi, Affirm, Robinhood, Coinbase, Chime, Klarna, Circle) sit at the intersection of
14 December 2025
················

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop